Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-24 @ 11:10 PM
NCT ID:
NCT03520569
Eligibility Criteria:
Inclusion Criteria:
* Healthy with no chronic illness
* Age 18-35
* Normal BMI (18-25)
* Normal screening labs or no clinically significant values
Exclusion Criteria:
* First degree relative with Type 2 Diabetes
* Smoking presently or in the past 6 months
* Medications that affect the vasculature
* Overweight or other indications of insulin resistance
* Elevated LDL cholesterol \> 160
* Elevated BP \> 140/90
* History of congestive heart failure, ischemic heart disease, severe pulmonary disease, liver or kidney disease, bleeding disorders
* Any vascular disease such as myocardial infarction, stroke, peripheral vascular disease
* Presence of an intracardiac or intrapulmonary shunt (we will screen for this by auscultation during the physical exam by PI).
* Pregnant or breastfeeding.
* Known hypersensitivity to perflutren (contained in Definity)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT03520569
Study Brief:
Protocol Section:
NCT03520569